Top Searches
Advertisement

Neuland Laboratories Posts Solid Q4, Declares ₹12 Dividend as Profits Jump


Updated: May 15, 2025 16:37

Image Source: Trade Brains
Neuland Laboratories Ltd has posted a solid financial performance for the quarter ending March 2025, reflecting its increasing pace in the pharma industry. The firm announced a ₹12 per share dividend, compensating shareholders after a run of sustained growth and profitability.
 
Highlights:
  • Sustained Revenue Growth: Consolidated revenue from operations during Q4 was ₹3.28 billion, indicating the company's robust demand and operating efficiency.
  • Surge in Profit: Consolidated net profit in the quarter amounted to ₹278.1 million, a sound profit margin reflecting Neuland's cost discipline and earnings growth capabilities.
  • Dividend to Shareholders: The board of directors suggested a ₹12 per share dividend, reinforcing the company's intent to provide value to shareholders.
  • Market Momentum: The shares of Neuland keep trading at sturdy levels, with a market cap of over ₹15,300 crore, more than doubling over the last one year.
  • Operational Excellence: The last quarters have witnessed significant revenue and EBITDA upticks, and the December 2024 quarter has already shown a 45% sequential top-line growth and more than 200% growth in net profits, laying an excellent foundation for 2025.
  • Strategic Initiatives: The company's emphasis on increasing its manufacturing footprint, particularly through new facilities in Telangana, is likely to continue to support growth opportunities and operating capacity.
  • Industry Outlook: Based on a strong pipeline and continued investments in R&D and capacity build, Neuland is poised to take advantage of heightened global demand for pharma ingredients.
Neuland Laboratories' recent results and dividend declaration reflect its solidity of finances, operating discipline, and favorable outlook for shareholders.
 
Source: Moneycontrol, Screener, BlinkX

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement